Posts with tag: acrylics
CVS stock rose nearly 15% after the company reported a beat on earnings and a conservative 2025 financial outlook. CEO David Joyner defended the company's pharmacy benefit manager unit, which has been under fire. CVS is also pivoting away from the traditional system of negotiating drug prices.
Published on: February 12, 2025, 10:01 PM UTC